Invention Grant
- Patent Title: Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
-
Application No.: US16037268Application Date: 2018-07-17
-
Publication No.: US10682393B2Publication Date: 2020-06-16
- Inventor: Shanthi Srinivasan
- Applicant: Emory University , U.S. Government represented by the United States Department of Veterans Affairs
- Applicant Address: US GA Atlanta US DC Washington
- Assignee: Emory University,The United States Department of Veterans Affairs
- Current Assignee: Emory University,The United States Department of Veterans Affairs
- Current Assignee Address: US GA Atlanta US DC Washington
- Agency: Emory Patent Group
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/475
Abstract:
The disclosure relates to therapeutic methods for regulating weight gain, metabolic syndrome, and insulin resistance. In certain embodiments, the disclosure relates to methods of treating or preventing obesity, metabolic syndrome, or insulin resistance by administering an effective amount of a pharmaceutical composition comprising one or more GDNF receptor agonists to a subject in need thereof.
Public/Granted literature
- US20180326009A1 Glial Cell Line Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions Public/Granted day:2018-11-15
Information query
IPC分类:
